Is Marl Drug Discovery Safe?
Marl Drug Discovery — Nerq Trust Score 52.2/100 (D grade). Score based on 5 independent trust signals.
Marl Drug Discovery is a software tool with a Nerq Trust Score of 52.2/100 (D), based on 5 independent data dimensions. Security: 0/100. Maintenance: 1/100. Popularity: 0/100. Data sourced from multiple public sources including package registries, GitHub, NVD, OSV.dev, and OpenSSF Scorecard. Last updated: n/a. Machine-readable data (JSON).
Is Marl Drug Discovery safe?
Trust Score Breakdown — Marl Drug Discovery has a Nerq Trust Score of 52.2/100 (D). Measured across 5 independent trust signals.
What is Marl Drug Discovery's trust score?
Marl Drug Discovery has a Nerq Trust Score of 52.2/100, earning a D grade. This score is based on 5 independently measured dimensions including security, maintenance, and community adoption.
What are the key security findings for Marl Drug Discovery?
Marl Drug Discovery's strongest signal is compliance at 48/100. No known vulnerabilities have been detected.
What is Marl Drug Discovery and who maintains it?
| Author | kainspraveen |
| Category | Research |
| Source | https://github.com/kainspraveen/marl-drug-discovery |
Regulatory Compliance
| EU AI Act Risk Class | MINIMAL |
| Compliance Score | 48/100 |
| Jurisdictions | Assessed across 52 jurisdictions |
Popular Alternatives in research
What Is Marl Drug Discovery?
Marl Drug Discovery is a software tool in the research category: A Multi Agent Reinforcement Learning framework for accelerating drug discovery.. Nerq Trust Score: 52/100 (D).
Nerq independently analyzes every software tool, app, and extension across multiple trust signals including security vulnerabilities, maintenance activity, license compliance, and community adoption.
How Nerq Assesses Marl Drug Discovery's Safety
Nerq's Trust Score is calculated from 13+ independent signals aggregated into five dimensions. Here is how Marl Drug Discovery performs in each:
- Security (0/100): Marl Drug Discovery's security posture is poor. This score factors in known CVEs, dependency vulnerabilities, security policy presence, and code signing practices.
- Maintenance (1/100): Marl Drug Discovery is potentially abandoned. We track commit frequency, release cadence, issue response times, and PR merge rates.
- Documentation (0/100): Documentation quality is insufficient. This includes README completeness, API documentation, usage examples, and contribution guidelines.
- Compliance (48/100): Marl Drug Discovery is compliance gaps exist. Assessed against regulations in 52 jurisdictions including the EU AI Act, CCPA, and GDPR.
- Community (0/100): Community adoption is limited. Based on GitHub stars, forks, download counts, and ecosystem integrations.
The overall Trust Score of 52.2/100 (D) is the weighted combination of these measured signals. It is a measurement, not a pass/fail or suitability judgment — weigh the individual signals against your own requirements.
Who Typically Evaluates Marl Drug Discovery?
Marl Drug Discovery is commonly evaluated by:
- Developers and teams working with research tools
- Organizations evaluating AI tools for their stack
- Researchers exploring AI capabilities in this domain
How to read the signals: Marl Drug Discovery's measured signals (security 0/100, maintenance 1/100, documentation 0/100, community 0/100) are shown above. These are measurements, not a suitability judgment — weigh each signal against the requirements of your own use case and risk tolerance.
How to Verify Marl Drug Discovery's Safety Yourself
While Nerq provides automated trust analysis, we recommend these additional steps before adopting any software tool:
- Check the source code — Review the repository's security policy, open issues, and recent commits for signs of active maintenance.
- Scan dependencies — Use tools like
npm audit,pip-audit, orsnykto check for known vulnerabilities in Marl Drug Discovery's dependency tree. - Review permissions — Understand what access Marl Drug Discovery requires. Software tools should follow the principle of least privilege.
- Test in isolation — Run Marl Drug Discovery in a sandboxed environment before granting access to production data or systems.
- Monitor continuously — Use Nerq's API to set up automated trust checks:
GET nerq.ai/v1/preflight?target=marl-drug-discovery - Review the license — Confirm that Marl Drug Discovery's license is compatible with your intended use case. Pay attention to restrictions on commercial use, redistribution, and derivative works. Some AI tools use dual licensing or have separate terms for enterprise customers that differ from the open-source license.
- Check community signals — Look at the project's issue tracker, discussion forums, and social media presence. A healthy community actively reports bugs, contributes fixes, and discusses security concerns openly. Low community engagement may indicate limited peer review of the codebase.
Common Safety Concerns with Marl Drug Discovery
When evaluating whether Marl Drug Discovery is safe, consider these category-specific risks:
Understand how Marl Drug Discovery processes, stores, and transmits your data. Review the tool's privacy policy and data retention practices, especially for sensitive or proprietary information.
Check Marl Drug Discovery's dependency tree for known vulnerabilities. Tools with outdated or unmaintained dependencies pose a higher security risk.
Regularly check for updates to Marl Drug Discovery. Security patches and bug fixes are only effective if you're running the latest version.
If Marl Drug Discovery connects to external APIs or services, each integration point is a potential attack surface. Audit all third-party connections, verify that data shared with external services is minimized, and ensure that integration credentials are rotated regularly.
Verify that Marl Drug Discovery's license is compatible with your intended use case. Some AI tools have restrictive licenses that limit commercial use, redistribution, or derivative works. Using Marl Drug Discovery in violation of its license can expose your organization to legal liability.
Marl Drug Discovery and the EU AI Act
Marl Drug Discovery is classified as Minimal Risk under the EU AI Act. This is the lowest risk category, meaning it faces minimal regulatory requirements. However, transparency obligations still apply.
Nerq's compliance assessment covers 52 jurisdictions worldwide. For organizations deploying AI tools in regulated environments, understanding these classifications is essential for legal compliance.
Best Practices for Using Marl Drug Discovery Safely
Whether you're an individual developer or an enterprise team, these practices will help you get the most from Marl Drug Discovery while minimizing risk:
Periodically review how Marl Drug Discovery is used in your workflow. Check for unexpected behavior, permissions drift, and compliance with your security policies.
Ensure Marl Drug Discovery and all its dependencies are running the latest stable versions to benefit from security patches.
Grant Marl Drug Discovery only the minimum permissions it needs to function. Avoid granting admin or root access.
Subscribe to Marl Drug Discovery's security advisories and vulnerability disclosures. Use Nerq's API to get automated trust score updates.
Create and maintain a clear policy for how Marl Drug Discovery is used within your organization, including data handling guidelines and acceptable use cases.
Situations That Warrant Independent Review of Marl Drug Discovery
Nerq's signals are one input. In the following situations, evaluate Marl Drug Discovery's measured signals against your own requirements before making a decision:
- Environments handling sensitive or regulated data (healthcare, finance, government)
- Mission-critical systems where downtime has significant business impact
- Deployments with strict regulatory requirements that must be independently validated
For each situation, compare Marl Drug Discovery's measured trust score of 52.2/100 and its individual signals against your organization's own criteria. Nerq does not assert whether Marl Drug Discovery is suitable for any particular use.
How Marl Drug Discovery Compares to Industry Standards
Nerq indexes over 6 million software tools, apps, and packages across dozens of categories. Among research tools, the average Trust Score is 62/100. Marl Drug Discovery's score of 52.2/100 is near the category average of 62/100.
This places Marl Drug Discovery in line with the typical research tool tool. It meets baseline expectations but does not distinguish itself from peers on trust metrics.
Industry benchmarks matter because they contextualize a tool's safety profile. A score that looks moderate in isolation may actually represent strong performance within a challenging category — or vice versa. Nerq's category-relative analysis helps teams make informed decisions by showing not just absolute quality, but how a tool ranks against its direct peers.
Trust Score History
Nerq continuously monitors Marl Drug Discovery and recalculates its Trust Score as new data becomes available. Our scoring engine ingests real-time signals from source repositories, vulnerability databases (NVD, OSV.dev), package registries, and community metrics. When a new CVE is published, a major release ships, or maintenance patterns change, Marl Drug Discovery's score is updated within 24 hours.
Historical trust trends reveal whether a tool is improving, stable, or declining over time. A tool that consistently maintains or improves its score demonstrates ongoing commitment to security and quality. Conversely, a downward trend may signal reduced maintenance, growing technical debt, or unresolved vulnerabilities. To track Marl Drug Discovery's score over time, use the Nerq API: GET nerq.ai/v1/preflight?target=marl-drug-discovery&include=history
Nerq retains trust score snapshots at regular intervals, enabling trend analysis across weeks and months. Enterprise users can access detailed historical reports showing how each dimension — security, maintenance, documentation, compliance, and community — has evolved independently, providing granular visibility into which aspects of Marl Drug Discovery are strengthening or weakening over time.
Marl Drug Discovery vs Alternatives
In the research category, Marl Drug Discovery scores 52.2/100. There are higher-scoring alternatives available. For a detailed comparison, see:
- Marl Drug Discovery vs gpt_academic — Trust Score: 60.9/100
- Marl Drug Discovery vs LlamaFactory — Trust Score: 83.7/100
- Marl Drug Discovery vs unsloth — Trust Score: 77.2/100
Key Takeaways
- Marl Drug Discovery has a measured Nerq Trust Score of 52.2/100 (D) — a composite of independent signals, not a suitability judgment.
- Among research tools, Marl Drug Discovery scores near the category average of 62/100 (a positional measurement relative to peers).
- The individual signals — security, maintenance, documentation, compliance, community — are shown above. Weigh them against your own requirements.
- Query the current measured values via Nerq's Preflight API.
Frequently Asked Questions
Is Marl Drug Discovery Safe?
What is Marl Drug Discovery's trust score?
What are safer alternatives to Marl Drug Discovery?
How often is Marl Drug Discovery's safety score updated?
Can I use Marl Drug Discovery in a regulated environment?
See Also
Disclaimer: Nerq trust scores are automated measurements based on publicly available signals. They are not endorsements, verdicts, or guarantees of suitability. Always evaluate the signals against your own requirements.